US Broker Ratings

Cytokinetics, Incorporated (CYTK): Investor Outlook Reveals 28.48% Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading player in the biotechnology sector, has captured the attention of investors with its robust revenue growth and promising drug pipeline...

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 14% Potential Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX) stands as a formidable entity in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unraveling a $38.71 Billion Biotechnology Powerhouse’s Growth Potential

Revolution Medicines, Inc. (NASDAQ: RVMD) is carving its niche in the healthcare sector, particularly in the biotechnology industry. With its focus on developing groundbreaking therapies for..

Sarepta Therapeutics (SRPT) Stock Analysis: Unveiling a 30% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (SRPT), a leading name in the biotechnology sector, is making waves with its focus on RNA-targeted therapeutics and gene therapy for rare diseases...

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovator with 71.44% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is capturing investor attention with its innovative approach to organ transplant therapy and a notable potential upside of 71.44%, according to..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Strong Buy Ratings Signal Potential Upside in Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS) disorders...

Viatris Inc. (VTRS) Stock Analysis: Exploring a 9% Upside Potential Amid Diverse Healthcare Offerings

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic medications. With..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 21.24% Potential Upside in the Healthcare Information Sector

For investors seeking opportunities within the healthcare information services industry, Doximity, Inc. (NYSE: DOCS) presents an intriguing case. With a market capitalization of $3.82 billion, this..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 17% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the medical instruments and supplies industry, continues to capture the attention of investors with its innovative solutions in..

Telix Pharmaceuticals Limited (TLX): Analyst Ratings Reveal a Potential 91.73% Upside for Investors

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising financial and operational metrics. Based in..

Corcept Therapeutics (CORT) Investor Outlook: Navigating Growth in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing investor attention with its promising position in the biotechnology sector. With a market capitalization of $9.37 billion, the company..

Masimo Corporation (MASI) Stock Analysis: Exploring Stability in Volatile Markets with a 24.99% ROE

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices sector, is catching the attention of investors with its robust financial performance and strategic product..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unpacking a 19% Revenue Growth and a Promising 11.73% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a notable player in the biotechnology sector, presents a compelling investment opportunity, driven by robust revenue growth and a promising upside..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 17.96% Upside Potential for Investors

Investors looking for opportunities in the healthcare sector might find IQVIA Holdings, Inc. (NYSE: IQV) an intriguing prospect. With a market capitalization of $31.9 billion, IQVIA..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Promising Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust revenue growth and potential upside, all while..

Regencell Bioscience Holdings (RGC): Navigating Volatility in the Healthcare Sector

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), is carving out a niche in the healthcare sector with a..

Edwards Lifesciences Corporation (EW) Stock Analysis: A Healthcare Powerhouse with a 6.77% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices sector, continues to capture investor interest with its advanced cardiovascular solutions. With a market capitalization..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Ups and Downs of a Genomics Leader

Illumina, Inc. (NASDAQ: ILMN) is a heavyweight in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $26.71 billion,..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Medtronic plc (MDT) Stock Analysis: Exploring a 21% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the healthcare sector specializing in medical devices, continues to draw investor attention with its diverse portfolio and robust financial..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds